Press Release

China has made itself the undisputed powerhouse in the Active Pharmaceutical Ingredient (API) market globally, redefining how pharmaceutical supply chains function. Around 20% of global API production and exports to

June 16, 2025

Industry Overview Europe’s active pharmaceutical ingredients (API) market was valued at $45.4 billion in 2024 and is projected to grow at a CAGR of 5.9% during the forecast period (2025-2035).

June 13, 2025

Imatinib Mesylate Market is driven by growing adoption of generic imatinib formulations across developing economies, improving drug accessibility and affordability. Industry Overview Imatinib mesylate market Imatinib mesylate, also known as

June 13, 2025

Industry Overview United States Active Pharmaceutical Ingredients (API) market is undergoing a dynamic phase, marked by high growth opportunities balanced with geopolitical and economic concerns. The U.S. API market stood

June 11, 2025

Growing global allergy prevalence, particularly allergic rhinitis and chronic urticaria, is significantly driving the demand for second-generation antihistamines. Industry Overview Desloratadine Desloratadine is an antihistamine that is used to obtain

June 11, 2025

Rising consumer shift toward preventive healthcare and vitamin-based therapies is boosting demand for benfotiamine. Industry Overview Benfotiamine The growth trend is influenced by the increasing application of this technology in

June 11, 2025

Hormone receptor-positive breast cancer, expanding generic drug access, and emerging applications in prostate cancer are propelling the global Anastrozole market forward. Industry Overview Anastrozole This expansion is largely fueled by

June 9, 2025

How can we help you?

Reach out to discuss how our team can help your business achieve real results.